Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha TeknovaTKNO +0.56%63 Quick Ratio is 3.60 as of Mar. 2026, which is 16% below its 10-year median of 4.27. GuruFocus rates TKNO with a GF Score™ of 63/100 and a GF Value™ of $3.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 997 Drug Manufacturers companies, Alpha Teknova ranks better than 81.24% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Alpha Teknova's quick ratio for the quarter that ended in Mar. 2026 was 3.60.
Alpha Teknova has a quick ratio of 3.60. It generally indicates good short-term financial strength.
The historical rank and industry rank for Alpha Teknova's Quick Ratio or its related term are showing as below:
TKNO'
s Quick Ratio Range Over the Past 10 Years
Min: 1.09 Med: 4.27 Max: 19.26
Current: 3.6
During the past 7 years, Alpha Teknova's highest Quick Ratio was 19.26. The lowest was 1.09. And the median was 4.27.
TKNO's Quick Ratio is ranked better than 81.24% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs TKNO: 3.60
Alpha Teknova (NAS:TKNO) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Alpha Teknova Quick Ratio Related Terms
Alpha Teknova Quick Ratio Historical Data
* Premium members only.
The historical data trend for Alpha Teknova's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alpha Teknova's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Teknova Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpha Teknova's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Alpha Teknova's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Alpha Teknova's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Teknova (TKNO) has a Quick Ratio of 3.60 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Alpha Teknova and its competitors. This is 16% below median its historical median of 4.27. Over the past decade, Alpha Teknova's Quick Ratio has ranged from 1.09 to 19.26. According to the industry distribution chart, Alpha Teknova ranks #187 out of 997 companies in the Drug Manufacturers industry, placing it in the top 18.8%.
Is Alpha Teknova's Quick Ratio too high?
Alpha Teknova's current Quick Ratio of 3.60 is 16% below median its 10-year median of 4.27. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 19.26. The Drug Manufacturers industry median Quick Ratio is 1.45. Alpha Teknova's value of 3.60 is 148.3% above this industry median. Based on the distribution chart, Alpha Teknova ranks #187 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha Teknova has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpha Teknova's Quick Ratio compare to AKBA and ORGO?
According to the Drug Manufacturers industry distribution chart, Alpha Teknova ranks #187 out of 997 companies for Quick Ratio. This places Alpha Teknova in the top 19% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Alpha Teknova's value of 3.60 is 148.3% above this benchmark. Historically, Alpha Teknova's own Quick Ratio has ranged from 1.09 to 19.26 over the past decade. While the company's 10-year median is 4.27 vs. the industry median of 1.45, Alpha Teknova has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Teknova's current Quick Ratio of 3.60 is 148.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Alpha Teknova and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Teknova's current Quick Ratio is 3.60, which is 16% below median its own 10-year median of 4.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Teknova stock overvalued right now?
Based on GuruFocus' analysis, Alpha Teknova (TKNO) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.55, compared to a current price of $5.34 — trading 50.4% above its estimated fair value. The current Quick Ratio is 3.60, which is 16% below median its 10-year median of 4.27 and 148.3% above the Drug Manufacturers industry median of 1.45. Alpha Teknova's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Alpha Teknova (TKNO), the current Quick Ratio is 3.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpha Teknova (TKNO) Overvalued in 2026?
Based on GuruFocus' analysis, Alpha Teknova stock appears to be overvalued.
The current stock price of $5.34 is trading 50.4% above its estimated GF Value™ of $3.55.
GuruFocus considers Alpha Teknova to be Significantly Overvalued.
Key valuation signals for TKNO:
Quick Ratio: 3.60 (16% below median its 10-year median of 4.27)
GF Value™: $3.55 vs. price of $5.34 (50.4% above fair value)
Industry Position: 148.3% above the Drug Manufacturers median (#187 of 997)
No single metric tells the full story. See the TKNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
63GF Score
Get the complete analysis for TKNO
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TKNO has been successfully added to your 
